Patient Fees Receivable (Details) - USD ($) |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
Dec. 31, 2021 |
|
| Patient Fees Receivable | |||||
| Financial Designation, Predecessor and Successor [Fixed List] | Successor | Predecessor | Successor | Predecessor | |
| Total Receivables: Gross | $ 5,383,421 | $ 5,383,421 | $ 2,641,182 | ||
| Less: Contractual Allowances | (4,745,367) | (4,745,367) | (1,968,750) | ||
| Receivables Net of Contractual Allowances | $ 638,054 | $ 638,054 | $ 672,432 | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right to consideration is unconditional, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right to consideration is unconditional, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right to consideration is unconditional, classified as current. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Indicates designation of financial information when substantially all business or separately identifiable line of business transfers from one entity to another entity. Acceptable values are "Predecessor" and "Successor". Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|